Effect of Structured Exercise in Patients With Knee Osteoarthritis
Effect of Nordic Walking and Inspiratory Muscle Training to Promote Cardiopulmonary Function in Patients With Knee Osteoarthritis
1 other identifier
interventional
80
1 country
1
Brief Summary
The aim of this randomized controlled trial is to evaluate the effect of Nordic walking and inspiratory muscle training (IMT) on cardiopulmonary function in patients with knee osteoarthritis (OA). Mild-to-moderate knee OA patients are randomly allocated into Experimental group (Nordic walking plus routine management) or Control group (Routine management). While End-stage knee OA patients are randomly allocated into Experimental group (IMT plus pre-operative rehabilitation exercise) or Control group (Pre-operative rehabilitation exercise). Participants are invited to undergo two assessments, including baseline assessment, post-intervention assessment. Researchers will compare two groups to see if the cardiopulmonary function can be improved after intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2023
CompletedStudy Start
First participant enrolled
October 5, 2023
CompletedFirst Posted
Study publicly available on registry
October 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
October 16, 2023
September 1, 2023
2.9 years
October 3, 2023
October 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
The six-minute walk test
Cardiopulmonary function
Baseline, up to 8 weeks
30-sec chair stand test
Cardiopulmonary function
Baseline, up to 8 weeks
Grip strength
Cardiopulmonary function
Baseline, up to 8 weeks
Timed up-and-go test
Cardiopulmonary function
Baseline, up to 8 weeks
Quadriceps strength
Cardiopulmonary function
Baseline, up to 8 weeks
Secondary Outcomes (13)
Forced vital capacity
Baseline, up to 8 weeks
Forced expiratory volume at first second
Baseline, up to 8 weeks
Maximum voluntary ventilation
Baseline, up to 8 weeks
Inspiratory muscle strength
Baseline, up to 8 weeks
Inspiratory muscle endurance
Baseline, up to 8 weeks
- +8 more secondary outcomes
Study Arms (2)
Nordic walking group or inspiratory muscle training
EXPERIMENTALIn experimental group, investigator will coordinate with the patients with mild-to-moderate knee osteoarthritis to take the Nordic walking, while the patients with end-stage knee osteoarthritis to take inspiratory muscle training. All participants are required to maintain their daily activities and routine management.
Control group
NO INTERVENTIONIn control group, participants are required to maintain their daily activities and routine management.
Interventions
Nordic walking is a form of low-impact aerobic exercise that incorporates the use of walking poles. And inspiratory muscle training is a type of exercise that provides resistance during the inhalation phase.
Eligibility Criteria
You may qualify if:
- pain on the most days in one or both knees in the past month;
- difficulty with at least one of daily living activities measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale;
- radiographic evidence of knee OA in the tibial-femoral compartment (Kellgren and Lawrence grade, K/L ≥1, K/L 1-3 regarded as mild-to-moderate knee OA, others waiting for knee arthroplasty regarded as end-stage knee OA);
- with normal or corrected visual and auditory function and walking unaided;
- primary knee OA for more than 6 months, be stable on medication for at least 3 weeks.
You may not qualify if:
- knee surgery priorly;
- have steroid injection in previous three weeks;
- have inflammatory arthritis (e.g., rheumatoid); or unstable angina, or myocardial infarction, or cardiac surgery; or stroke; or treatment with steroids, hormones, or cancer chemotherapy; or pulmonary diseases (force vital capacity\<80% of predicted and/or forced expiratory volume at first second\<70% of predicted); or a history of exercise-induced asthma;
- unable to understand the procedure and potential risks of the study;
- medically unstable that indicate unsafe to participate in exercise test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hong Kong Polytechnic Universitylead
- Kwong Wah Hospitalcollaborator
Study Sites (1)
The Hong Kong Polytechnic University
Kowloon City, Kowloon, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy FU, PhD
Department of Rehabilitation Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Investigator and outcomes assessor won't know the allocation of participants.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2023
First Posted
October 16, 2023
Study Start
October 5, 2023
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
October 16, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make individual participant data available to other researchers.